Specific Inhibition of β-Secretase Processing of the Alzheimer Disease Amyloid Precursor Protein
Development of disease-modifying therapeutics is urgently needed for treating Alzheimer disease (AD). AD is characterized by toxic β-amyloid (Aβ) peptides produced by β- and γ-secretase-mediated cleavage of the amyloid precursor protein (APP). β-secretase inhibitors reduce Aβ levels, but mechanism-b...
Main Authors: | Saoussen Ben Halima, Sabyashachi Mishra, K. Muruga Poopathi Raja, Michael Willem, Antonio Baici, Kai Simons, Oliver Brüstle, Philipp Koch, Christian Haass, Amedeo Caflisch, Lawrence Rajendran |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2016-03-01
|
Series: | Cell Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124716300754 |
Similar Items
-
Beta-Secretase 1 Recruits Amyloid-Beta Precursor Protein to ROCK2 Kinase, Resulting in Erroneous Phosphorylation and Beta-Amyloid Plaque Formation
by: István Hajdú, et al.
Published: (2023-06-01) -
Partial reduction of amyloid β production by β-secretase inhibitors does not decrease synaptic transmission
by: Tugce Munise Satir, et al.
Published: (2020-05-01) -
BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer’s Disease
by: Miguel A. Maia, et al.
Published: (2019-03-01) -
Secretases Related to Amyloid Precursor Protein Processing
by: Xiaoling Liu, et al.
Published: (2021-12-01) -
Sex differences in circulating neuregulin1-β1 and β-secretase 1 expression in childhood-onset schizophrenia
by: Zhengrong Zhang, et al.
Published: (2020-07-01)